"Visit the Planned Parenthood health center in Tulsa, OK for the morning after pill (emergency contraception), abortion, pregnancy testing, STD treatment, birth control, and sexual and reproductive health care."

During the past decade, Planned Parenthood of Arkansas and Eastern Oklahoma conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Planned Parenthood of Arkansas and Eastern Oklahoma" are "Cystitis, Interstitial" (1 trials), "Endometriosis" (1 trials) and "Genital Herpes" (1 trials). Many other conditions were trialed in "Planned Parenthood of Arkansas and Eastern Oklahoma" in a lesser frequency.

Most popular intervention types in "Planned Parenthood of Arkansas and Eastern Oklahoma" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tanezumab" (2 trials) and "Famciclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Planned Parenthood of Arkansas and Eastern Oklahoma" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Planned Parenthood of Arkansas and Eastern Oklahoma". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Planned Parenthood of Arkansas and Eastern Oklahoma, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Planned Parenthood of Arkansas and Eastern Oklahoma, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".